Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It also engages in the cultivation, processing, and sale of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and … Read more
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.023x
Based on the latest financial reports, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a cash flow conversion efficiency ratio of -0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.57 Million) by net assets (CN¥756.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi JDL Environmental Protection Co. Ltd. A
SHG:688057
|
0.015x |
|
BRAZIL RES
F:BSR
|
-0.043x |
|
HEBA Fastighets AB (publ)
ST:HEBA-B
|
0.002x |
|
Renxin New Material Co. Ltd. A
SHE:301395
|
N/A |
|
Favite Inc
TW:3535
|
0.039x |
|
Changzhou Tiansheng New Materials Co Ltd
SHE:300169
|
-0.048x |
|
WATERSTONE FINL (MD.)
F:47Z
|
N/A |
|
Rongyu Group Co Ltd
SHE:002622
|
0.042x |
Annual Cash Flow Conversion Efficiency for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥727.93 Million | CN¥170.14 Million | 0.234x | +72.29% |
| 2023-12-31 | CN¥711.51 Million | CN¥96.53 Million | 0.136x | +806.01% |
| 2022-12-31 | CN¥763.13 Million | CN¥11.43 Million | 0.015x | -78.54% |
| 2021-12-31 | CN¥732.84 Million | CN¥51.13 Million | 0.070x | +18.56% |
| 2020-12-31 | CN¥739.13 Million | CN¥43.50 Million | 0.059x | +54.16% |
| 2019-12-31 | CN¥738.88 Million | CN¥28.21 Million | 0.038x | +168.93% |
| 2018-12-31 | CN¥720.83 Million | CN¥10.23 Million | 0.014x | +592.28% |
| 2017-12-31 | CN¥712.19 Million | CN¥-2.05 Million | -0.003x | -115.45% |
| 2016-12-31 | CN¥703.74 Million | CN¥13.14 Million | 0.019x | -75.26% |
| 2015-12-31 | CN¥405.57 Million | CN¥30.60 Million | 0.075x | -29.77% |
| 2014-12-31 | CN¥363.10 Million | CN¥39.01 Million | 0.107x | -4.61% |
| 2013-12-31 | CN¥318.92 Million | CN¥35.92 Million | 0.113x | -45.79% |
| 2012-12-31 | CN¥171.46 Million | CN¥35.62 Million | 0.208x | -7.30% |
| 2011-12-31 | CN¥45.35 Million | CN¥10.16 Million | 0.224x | -- |